Abstract:Dengue is a major public health concern, affecting almost 400 million people worldwide, with about 70% of the global burden of disease in Asia. Despite revised clinical classifications of dengue infections by the World Health Organization, the wide spectrum of the manifestations of dengue illness continues to pose challenges in diagnosis and patient management for clinicians. When the Zika epidemic spread through the American continent and then later to Africa and Asia in 2015, researchers compared the characteristics of the Zika infection to Dengue, considering both these viruses were transmitted primarily through the same vector, the Aedes aegypti female mosquitoes. An important difference to note, however, was that the Zika epidemic diffused in a shorter time span compared to the persisting feature of Dengue infections, which is endemic in many Asian countries. As the pathogenesis of viral illnesses is affected by host immune responses, various immune modulators have been proposed as biomarkers to predict the risk of the disease progression to a severe form, at a much earlier stage of the illness. However, the findings for most biomarkers are highly discrepant between studies. Meanwhile, the cross-reactivity of CD8+ and CD4+ T cells response to Dengue and Zika viruses provide important clues for further development of potential treatments. This review discusses similarities between Dengue and Zika infections, comparing their disease transmissions and vectors involved, and both the innate and adaptive immune responses in these infections. Consideration of the genetic identity of both the Dengue and Zika flaviviruses as well as the cross-reactivity of relevant T cells along with the actions of CD4+ cytotoxic cells in these infections are also presented. Finally, a summary of the immune biomarkers that have been reported for dengue and Zika viral infections are discussed which may be useful indicators for future anti-viral targets or predictors for disease severity. Together, this information appraises the current understanding of both Zika and Dengue infections, providing insights for future vaccine design approaches against both viruses.

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

Advances in Zika Virus–Host Cell Interaction: Current Knowledge and Future Perspectives

Host immune response against DENV and ZIKV infections

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

The emergence of Zika virus and its new clinical syndromes

Targeting Type I Interferon Induction and Signaling: How Zika Virus Escapes from Host Innate Immunity

Zika virus: The transboundary pathogen from mosquito and updates.

Zika virus tropism and pathogenesis: understanding clinical impacts and transmission dynamics

Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells

Recent progresses and remaining challenges for the detection of Zika virus

The mechanisms of Zika virus-induced neuropathogenesis

From Mosquito Bites to Sexual Transmission: Evaluating Mouse Models of Zika Virus Infection

ZIKV viral proteins and their roles in virus-host interactions

Virological Characteristics of Zika Virus and Abnormal Immune Responses Induced by Zika Virus

Zika Virus: An Emerging Global Health Threat

Zika virus reservoirs: Implications for transmission, future outbreaks, drug and vaccine development

Host and viral mechanisms of congenital Zika syndrome

Modulation of cellular machineries by Zika virus‐encoded proteins

Modulation of Cellular Machineries by Zika Virus-Encoded Proteins

Zika Virus Infection Reprograms Global Transcription of Host Cells to Allow Sustained Infection

Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology